COVID-19

Chicago emerging as life science and biopharma hub

Chicago emerging as a life science and biopharma hub

By Jane Byrne

Many turn to Boston and North Carolina’s Research Triangle to set up life science companies, but Chicago is now also fast becoming a draw in this respect. The city is emerging as a life science and biopharma hub and seems poised for even further growth,...

Pic:getty/oatawa

Pfizer ups COVID-19 vaccine revenue estimates

By Rachel Arthur

Pfizer has upped its 2021 sales forecast for its mRNA COVID-19 vaccine to $26bn: as well as reporting strong Q1 results for the business overall this morning.

Pic:getty/nezman

GSK to help manufacture Novavax COVID-19 vaccine

By Rachel Arthur

GSK will help manufacture up to 60 million doses of Novavax’s COVID-19 vaccine from its facility at Barnard Castle in the UK, with doses to be distributed in the country.

© GettyImages/solarseven

Raft of Indian pharma firms set to produce Sputnik V vaccine

By Jane Byrne

The RDIF, Russia’s sovereign wealth fund, and India based, Virchow Biotech Private Limited, have today announced a partnership to produce and supply a minimum of 200 million doses of the Russia developed Sputnik V vaccine against COVID-19.